BackShin Nippon Biomedical Laboratories, Overview

Shin Nippon Biomedical Laboratories, Goodwill

Shin Nippon Biomedical Laboratories,'s goodwill is $1.7B.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$1.75B
↓ 4.27% YoYΔ $-77.89M vs prior year quarter

Peer trimmed avg / median

Loading

Shin Nippon Biomedical Laboratories, Goodwill History

Loading

Shin Nippon Biomedical Laboratories, vs. peers: Goodwill Comparison

Loading

Shin Nippon Biomedical Laboratories, Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Shin Nippon Biomedical Laboratories, (2395.T) FAQ

As of the most recent data (June 2026), 2395.T shows a goodwill of $1.7B. That compares with $1.8B in the prior-year period — down 4.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 2395.T's goodwill is now $1.7B (was $1.8B) — a 4.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Shin Nippon Biomedical Laboratories, is outperforming or lagging.

Tracking 2395.T's goodwill over time shows whether Shin Nippon Biomedical Laboratories, is scaling, shrinking, or reshaping that part of the business. The current reading is $1.7B That compares with $1.8B in the prior-year period — down 4.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has Shin Nippon Biomedical Laboratories,'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $1.7B) with ownership activity and broader fundamentals.